BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 11585418)

  • 1. Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival.
    Krivak TC; Seidman JD; McBroom JW; MacKoul PJ; Aye LM; Rose GS
    Gynecol Oncol; 2001 Oct; 83(1):89-94. PubMed ID: 11585418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended surgical staging for uterine papillary serous carcinoma: survival outcome of locoregional (Stage I-III) disease.
    Bristow RE; Asrari F; Trimble EL; Montz FJ
    Gynecol Oncol; 2001 May; 81(2):279-86. PubMed ID: 11330963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic parameters in carcinosarcomas of the uterus: a clinico-pathologic study.
    Bodner-Adler B; Bodner K; Obermair A; Czerwenka K; Petru E; Leodolter S; Mayerhofer K
    Anticancer Res; 2001; 21(4B):3069-74. PubMed ID: 11712812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of cytoreductive surgery in the management of stage IV uterine papillary serous carcinoma.
    Bristow RE; Duska LR; Montz FJ
    Gynecol Oncol; 2001 Apr; 81(1):92-9. PubMed ID: 11277657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinosarcoma of the uterus: a clinicopathological multicenter CTF study.
    Sartori E; Bazzurini L; Gadducci A; Landoni F; Lissoni A; Maggino T; Zola P; La Face B
    Gynecol Oncol; 1997 Oct; 67(1):70-5. PubMed ID: 9345359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of postoperative treatment on survival in patients with uterine papillary serous carcinoma.
    Bancher-Todesca D; Neunteufel W; Williams KE; Prainsack D; Breitenecker G; Friedlander ML; Hacker NF
    Gynecol Oncol; 1998 Dec; 71(3):344-7. PubMed ID: 9887228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice].
    Farzad M; De Luca MC; Rubino G; Pirtoli L; Pepi F; Sebaste L; Ponticelli P; Atzeni G; Maranzano E; Silvano G
    Radiol Med; 2001; 102(1-2):72-7. PubMed ID: 11677442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgery and adjuvant radiation therapy of endometrial stromal sarcoma.
    Weitmann HD; Kucera H; Knocke TH; Pötter R
    Wien Klin Wochenschr; 2002 Jan; 114(1-2):44-9. PubMed ID: 12407935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of uterine Müllerian adenosarcoma with extrauterine metastatic deposits.
    Guidozzi F; Smith T; Koller AB; Reinecke L
    Gynecol Oncol; 2000 Jun; 77(3):464-6. PubMed ID: 10831361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodality therapy in early-stage neuroendocrine carcinoma of the uterine cervix.
    Boruta DM; Schorge JO; Duska LA; Crum CP; Castrillon DH; Sheets EE
    Gynecol Oncol; 2001 Apr; 81(1):82-7. PubMed ID: 11277655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival of women with surgical stage II endometrial cancer.
    Eltabbakh GH; Moore AD
    Gynecol Oncol; 1999 Jul; 74(1):80-5. PubMed ID: 10385555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of adjuvant radiotherapy on carcinosarcoma of the uterus.
    Gerszten K; Faul C; Kounelis S; Huang Q; Kelley J; Jones MW
    Gynecol Oncol; 1998 Jan; 68(1):8-13. PubMed ID: 9454652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uterine leiomyosarcoma: analysis of treatment failures and survival.
    Gadducci A; Landoni F; Sartori E; Zola P; Maggino T; Lissoni A; Bazzurini L; Arisio R; Romagnolo C; Cristofani R
    Gynecol Oncol; 1996 Jul; 62(1):25-32. PubMed ID: 8690287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial.
    Trimbos JB; Vergote I; Bolis G; Vermorken JB; Mangioni C; Madronal C; Franchi M; Tateo S; Zanetta G; Scarfone G; Giurgea L; Timmers P; Coens C; Pecorelli S;
    J Natl Cancer Inst; 2003 Jan; 95(2):113-25. PubMed ID: 12529344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A clinical analysis of 153 uterine sarcomas].
    Bai P; Sun J; Chao H
    Zhonghua Fu Chan Ke Za Zhi; 1997 Mar; 32(3):163-7. PubMed ID: 9596892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulosa cell tumor of the ovary: a population-based study of 37 women with stage I disease.
    Lauszus FF; Petersen AC; Greisen J; Jakobsen A
    Gynecol Oncol; 2001 Jun; 81(3):456-60. PubMed ID: 11371138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uterine papillary serous carcinoma: evaluation of long-term survival in surgically staged patients.
    Grice J; Ek M; Greer B; Koh WJ; Muntz HG; Cain J; Tamimi H; Stelzer K; Figge D; Goff BA
    Gynecol Oncol; 1998 Apr; 69(1):69-73. PubMed ID: 9571001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodality therapy for patients with clinical Stage I and II malignant mixed Müllerian tumors of the uterus.
    Manolitsas TP; Wain GV; Williams KE; Freidlander M; Hacker NF
    Cancer; 2001 Apr; 91(8):1437-43. PubMed ID: 11301390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uterine papillary serous carcinoma.
    Chambers JT; Merino M; Kohorn EI; Peschel RE; Schwartz PE
    Obstet Gynecol; 1987 Jan; 69(1):109-13. PubMed ID: 3796910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presentation and management of carcinosarcoma of the uterus.
    Vaccarello L; Curtin JP
    Oncology (Williston Park); 1992 May; 6(5):45-9; discussion 53-4, 59. PubMed ID: 1534676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.